Rivanna Medical
Charlottesville, US · Virginia LLC
RIVANNA builds AI-powered ultrasound imaging platforms that provide clinical decision support at the point of care, including procedural guidance for neuraxial anesthesia (spinal needle intervention) and bedside fracture triage for emergency medicine. Its products, such as the FDA-cleared Accuro system, use automated 3D imaging and needle-tracking technology to reduce operator variability for clinicians and healthcare facilities.
Founders & leadership
Board
Reported raises · per SEC filings
Form D private placements$3.2M disclosed across 2 rounds · 2015–2016
▶$3MraisedAug 2016 · 5 investors · Other Health CareRule 506(b)
- Frank William Mauldin, Jr.Executive Officer, Director
- Kevin OwenDirector
- G. Wayne MooreDirector
- Timothy R. OberDirector
- Joel B. WeinsteinDirector
- Offering amount
- $4M
- Amount sold
- $3M
- Minimum investment
- $8.5K
- Proceeds to insiders
- $180K
- First sale
- Jul 2016
- Incorporated
- Limited Liability Company, Virginia
- Federal exemptions
- 06b
▶$200.4KraisedDec 2015 · 3 investors · Other Health CareRule 506(b)
- Timothy R. OberDirector
- Kevin OwenDirector, Promoter
- Frank William Mauldin, Jr.Executive Officer, Director, Promoter
- John A. WilliamsExecutive Officer
- G. Wayne MooreDirector
- Giorgio BrusaDirector, Promoter
- Offering amount
- $1.5M
- Amount sold
- $200.4K
- Proceeds to insiders
- $175K
- First sale
- Nov 2015
- Incorporated
- Limited Liability Company, Virginia
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 12 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2023 | $1M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2022 | $745.1K |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $2.7M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2021 | $1.7M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2020 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2017 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2016 | $1.5M |
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2014 | $1.4M |
| National Science Foundation | Phase II | 2013 | $750K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2013 | $210.4K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2012 | $231.9K |
| National Science Foundation | Phase I | 2012 | $149.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Rivanna Medical do?
- RIVANNA builds AI-powered ultrasound imaging platforms that provide clinical decision support at the point of care, including procedural guidance for neuraxial anesthesia (spinal needle intervention) and bedside fracture triage for emergency medicine. Its products, such as the FDA-cleared Accuro system, use automated 3D imaging and needle-tracking technology to reduce operator variability for clinicians and healthcare facilities.
- Who founded Rivanna Medical?
- Rivanna Medical was founded by Frank William Mauldin, Jr..
- How much funding has Rivanna Medical raised?
- Rivanna Medical has disclosed $3.2M raised across 2 rounds.
- Where is Rivanna Medical headquartered?
- Rivanna Medical is headquartered in Charlottesville, US.